Patents by Inventor Heidi Lopez de Diego

Heidi Lopez de Diego has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID FORMULATIONS OF SALTS OF 4-[2-(4-METHYLPHENYLSULFANYL)PHENYL]PIPERIDINE
    Publication number: 20100105730
    Abstract: Liquid formulations of the DL-lactic acid, the glutaric acid, the L-aspartic acid and the glutamic acid salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine and their use in the manufacture of a medicament to be used in the treatment of CNS diseases are provided.
    Type: Application
    Filed: March 14, 2008
    Publication date: April 29, 2010
    Applicant: H. Lundbeck A/S
    Inventors: Gudrun Lasskogen, Tine Bryan Stensbol, Heidi Lopez de Diego
  • Crystalline base of -1-(()-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
    Patent number: 7648991
    Abstract: Crystalline base of compound trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine, processes for the preparation of purified free base or salts of this compound, pharmaceutical compositions comprising the base and medical use thereof, including for treatment of schizophrenia and other psychotic disorders.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: January 19, 2010
    Assignee: H. Lundbeck A/S
    Inventors: Benny Bang-Andersen, Heidi Lopez de Diego
  • CRYSTALLINE FORMS OF 4- [2- (4-METHYLPHENYLSULFANYL) -PHENYL] PIPERIDINE WITH COMBINED SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITION FOR THE TREATMENT OF NEUROPATHIC PAIN
    Publication number: 20090264465
    Abstract: Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine and salts thereof are provided e.g. for the treatment of neuropathic pain.
    Type: Application
    Filed: June 15, 2007
    Publication date: October 22, 2009
    Applicant: H. LUNDBECK A/S
    Inventors: Benny Bang-Andersen, Andre Faldt, Tine Bryan Stensbol, Silke Miller, Heidi Lopez De Diego
  • Tartrate and Malate Salts of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine
    Publication number: 20080269248
    Abstract: A tartrate and malate salt of trans-1-(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine, in particular for medical use, pharmaceutical formulations thereof, including for treatment of schizophrenia or other diseases involving psychotic symptoms.
    Type: Application
    Filed: February 14, 2006
    Publication date: October 30, 2008
    Applicant: H. Lundbeck A/S
    Inventors: Ole Nielsen, Heidi Lopez de Diego, Benny Bang-Andersen
  • Crystalline Base of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine
    Publication number: 20080153848
    Abstract: Crystalline base of compound trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine, processes for the preparation of purified free base or salts of this compound, pharmaceutical compositions comprising the base and medical use thereof, including for treatment of schizophrenia and other psychotic disorders.
    Type: Application
    Filed: February 14, 2006
    Publication date: June 26, 2008
    Applicant: H. Lundbeck A/S
    Inventors: Benny Bang-Andersen, Heidi Lopez De Diego
  • Crystalline forms of a pharmaceutical compound
    Publication number: 20070191339
    Abstract: Described are crystalline forms of the pharmaceutical compound “[9S-(9?,10?,12?)]-5,16-Bis[(ethylthio)methyl]-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9, 12-epoxy-1H-diindolo[1,2,3-fg:3?,2?,1?-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester”, as well as methods for their use and preparation.
    Type: Application
    Filed: February 24, 2005
    Publication date: August 16, 2007
    Applicant: H. Lundbeck A/S
    Inventors: Michael Rock, Heidi Lopez De Diego, Kim Christensen, Ole Nielsen, Anders Buur, Mark Howells
  • 1'-[4-[1-(4-fluorophenyl)-1H-indole-3-Y1]-spiro[isobenzofuran-1(3H), 4'-piperidine]hydrohalogenides
    Publication number: 20050171135
    Abstract: The present invention relates to a hydrohalogenide of 1?-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4?-piperidine], pharmaceutical compositions containing the acid addition salts and the use thereof for the treatment of psychic and neurological disorders.
    Type: Application
    Filed: December 13, 2004
    Publication date: August 4, 2005
    Applicant: H. Lundbeck A/S
    Inventors: Niels Mork, Heidi Lopez de Diego, Ole Nielsen
  • 1?-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4?-piperidine] hydrohalogenides
    Patent number: 6844352
    Abstract: The present invention relates to a hydrohalogenide of 1?-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4?-piperidine], pharmaceutical compositions containing the acid addition salts and the use thereof for the treatment of psychic and neurological disorders.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: January 18, 2005
    Assignee: H. Lundbeck A/S
    Inventors: Niels Mørk, Heidi Lopez de Diego, Ole Nielsen
  • 1'-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4'-piperidine] hydrohalogenides
    Publication number: 20030055074
    Abstract: The present invention relates to a hydrohalogenide of 1′-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4′-piperidine], pharmaceutical compositions containing the acid addition salts and the use thereof for the treatment of psychic and neurological disorders.
    Type: Application
    Filed: October 15, 2002
    Publication date: March 20, 2003
    Applicant: H. Lundbeck A/S
    Inventors: Niels Mork, Heidi Lopez de Diego, Ole Nielsen